Literature DB >> 29337182

Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.

Takashi Seino1, Shintaro Kawasaki1, Mariko Shimokawa1, Hiroki Tamagawa1, Kohta Toshimitsu1, Masayuki Fujii1, Yuki Ohta1, Mami Matano1, Kosaku Nanki1, Kenta Kawasaki1, Sirirat Takahashi1, Shinya Sugimoto1, Eisuke Iwasaki1, Junichi Takagi2, Takao Itoi3, Minoru Kitago4, Yuko Kitagawa4, Takanori Kanai1, Toshiro Sato5.   

Abstract

Despite recent efforts to dissect the inter-tumor heterogeneity of pancreatic ductal adenocarcinoma (PDAC) by determining prognosis-predictive gene expression signatures for specific subtypes, their functional differences remain elusive. Here, we established a pancreatic tumor organoid library encompassing 39 patient-derived PDACs and identified 3 functional subtypes based on their stem cell niche factor dependencies on Wnt and R-spondin. A Wnt-non-producing subtype required Wnt from cancer-associated fibroblasts, whereas a Wnt-producing subtype autonomously secreted Wnt ligands and an R-spondin-independent subtype grew in the absence of Wnt and R-spondin. Transcriptome analysis of PDAC organoids revealed gene-expression signatures that associated Wnt niche subtypes with GATA6-dependent gene expression subtypes, which were functionally supported by genetic perturbation of GATA6. Furthermore, CRISPR-Cas9-based genome editing of PDAC driver genes (KRAS, CDKN2A, SMAD4, and TP53) demonstrated non-genetic acquisition of Wnt niche independence during pancreas tumorigenesis. Collectively, our results reveal functional heterogeneity of Wnt niche independency in PDAC that is non-genetically formed through tumor progression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas9; GATA6; Wnt; organoids; pancreatic cancer; stem cell niche

Mesh:

Substances:

Year:  2018        PMID: 29337182     DOI: 10.1016/j.stem.2017.12.009

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  147 in total

1.  YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma.

Authors:  Bo Tu; Jun Yao; Sammy Ferri-Borgogno; Jun Zhao; Shujuan Chen; Qiuyun Wang; Liang Yan; Xin Zhou; Cihui Zhu; Seungmin Bang; Qing Chang; Christopher A Bristow; Ya'an Kang; Hongwu Zheng; Huamin Wang; Jason B Fleming; Michael Kim; Timothy P Heffernan; Giulio F Draetta; Duojia Pan; Anirban Maitra; Wantong Yao; Sonal Gupta; Haoqiang Ying
Journal:  JCI Insight       Date:  2019-11-01

2.  Bladder organoids: a step towards personalised cancer therapy?

Authors:  Sreemoti Banerjee; Jennifer Southgate
Journal:  Transl Androl Urol       Date:  2019-07

3.  Generation and characterization of a cell line from an intraductal tubulopapillary neoplasm of the pancreas.

Authors:  Matthäus Felsenstein; Maria A Trujillo; Bo Huang; Neha Nanda; Zhengdong Jiang; Yea Ji Jeong; Michael Pflüger; Michael G Goggins; Ralph H Hruban; Elizabeth D Thompson; Christopher M Heaphy; Nicholas J Roberts; Laura D Wood
Journal:  Lab Invest       Date:  2020-01-31       Impact factor: 5.662

Review 4.  Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.

Authors:  Ryan C Smith; Viviane Tabar
Journal:  Cell Stem Cell       Date:  2018-12-20       Impact factor: 24.633

5.  Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells.

Authors:  Antonella F M Dost; Aaron L Moye; Marall Vedaie; Linh M Tran; Eileen Fung; Dar Heinze; Carlos Villacorta-Martin; Jessie Huang; Ryan Hekman; Julian H Kwan; Benjamin C Blum; Sharon M Louie; Samuel P Rowbotham; Julio Sainz de Aja; Mary E Piper; Preetida J Bhetariya; Roderick T Bronson; Andrew Emili; Gustavo Mostoslavsky; Gregory A Fishbein; William D Wallace; Kostyantyn Krysan; Steven M Dubinett; Jane Yanagawa; Darrell N Kotton; Carla F Kim
Journal:  Cell Stem Cell       Date:  2020-09-04       Impact factor: 24.633

Review 6.  Organoid models for translational pancreatic cancer research.

Authors:  Hervé Tiriac; Dennis Plenker; Lindsey A Baker; David A Tuveson
Journal:  Curr Opin Genet Dev       Date:  2019-03-04       Impact factor: 5.578

7.  Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Francisca Beato; Dayana Reverón; Kaleena B Dezsi; Antonio Ortiz; Joseph O Johnson; Dung-Tsa Chen; Karla Ali; Sean J Yoder; Daniel Jeong; Mokenge Malafa; Pamela Hodul; Kun Jiang; Barbara A Centeno; Mahmoud A Abdalah; Jodi A Balasi; Alexandra F Tassielli; Bhaswati Sarcar; Jamie K Teer; Gina M DeNicola; Jennifer B Permuth; Jason B Fleming
Journal:  Lab Invest       Date:  2020-10-09       Impact factor: 5.662

8.  Pancreatic cancer organoids recapitulate disease and allow personalized drug screening.

Authors:  Else Driehuis; Arne van Hoeck; Kat Moore; Sigrid Kolders; Hayley E Francies; M Can Gulersonmez; Edwin C A Stigter; Boudewijn Burgering; Veerle Geurts; Ana Gracanin; Gergana Bounova; Folkert H Morsink; Robert Vries; Sylvia Boj; Johan van Es; G Johan A Offerhaus; Onno Kranenburg; Mathew J Garnett; Lodewyk Wessels; Edwin Cuppen; Lodewijk A A Brosens; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-09       Impact factor: 11.205

Review 9.  Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.

Authors:  Tu-Xiong Huang; Xin-Yuan Guan; Li Fu
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

10.  Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.

Authors:  Hiroyuki Kato; Keisuke Tateishi; Hiroaki Fujiwara; Hideaki Ijichi; Keisuke Yamamoto; Takuma Nakatsuka; Miwako Kakiuchi; Makoto Sano; Yotaro Kudo; Yoku Hayakawa; Hayato Nakagawa; Yasuo Tanaka; Motoyuki Otsuka; Yoshihiro Hirata; Makoto Tachibana; Yoichi Shinkai; Kazuhiko Koike
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.